STOCK-BASED COMPENSATION | NOTE 7 — STOCK-BASED COMPENSATION We account for stock-based compensation by applying a fair-value-based measurement method to account for stock-based payment transactions with employees and directors, and record compensation cost for all stock awards granted after January 1, 2006 and awards modified, repurchased, or cancelled after that date, using the modified prospective method. We record compensation costs associated with the vesting of unvested options on a straight-line basis over the vesting period. We recognized $0.2 million of compensation expense in the consolidated statements of operations, with respect to our stock-based compensation plans for the years ended December 31, 2021 and 2020. The following table summarizes stock-based compensation expenses recorded in the consolidated statements of operations (in thousands): For the Years Ended December 31, 2021 2020 General and administrative $ 248 $ 221 Total stock-based compensation $ 248 $ 221 Stock Incentive Plans In June 2007, our stockholders approved the 2007 Stock Incentive Plan (the “2007 Stock Plan”) with a maximum of 1.0 million shares reserved for issuance. In June 2010, our stockholders approved an amendment to the 2007 Stock Plan which increased the maximum shares that may be awarded under the plan to 1.25 million. In June 2013, our stockholders approved an amendment to the 2007 Stock Plan which increased the maximum shares that may be awarded under the plan to 1.5 million. In June 2015, our stockholders approved an amendment to the 2007 Stock Plan which increased the maximum shares that may be awarded under the plan to 2.0 million. Awards permitted under the 2007 Stock Plan included: Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards and Other Stock-Based Awards. Awards issued under the 2007 Stock Plan are at the discretion of the Board of Directors. As applicable, awards were granted with an exercise price equal to the closing price of our common stock on the date of grant, generally vested over four years for employees and one year for directors and, with respect to stock option grants, expired no more than ten years from the date of grant. At December 31, 2021 and 2020, no shares were available for grant under the 2007 Stock Plan, as amended. At December 31, 2021 and 2020, 0.1 million options and restricted shares and 0.2 million options and restricted shares were issued outstanding In June 2016, our stockholders approved the 2016 Stock Incentive Plan (the “2016 Stock Plan”) with a maximum of 0.25 million shares reserved for issuance. In June 2018, our stockholders approved an amendment to the 2016 Stock Plan which increased the maximum shares that may be awarded under the plan to 0.85 million Awards permitted under the 2016 Stock Plan include: Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Awards and Other Stock-Based Awards. Awards issued under the 2016 Stock Plan are at the discretion of the Board of Directors. As applicable, awards are granted with an exercise price equal to the closing price of our common stock on the date of grant, generally vest over four years for employees and three years for an initial grant and one year for subsequent grants for directors and expire no more than ten years from the date of grant. At December 31, 2021 and 2020, there were approximately 0.6 million and 0.5 million shares available for grant under the 2016 Stock Plan, respectively. At December 31, 2021 and 2020, 0.1 million options and no restricted shares and 0.2 million options and restricted shares were issued The following is a summary of restricted stock activity under the plans for the years ended December 31, 2021 and 2020: Restricted Stock Number of Shares (In thousands) Unvested restricted stock at January 1, 2020 159 Less restricted stock vested (32) Less restricted stock forfeited/expired (64) Unvested restricted stock at December 31, 2020 63 Less restricted stock vested (63) Unvested restricted stock at December 31, 2021 — No grants were made during the year ending December 31, 2021 and 2020. During the years ended December 31, 2021 and 2020, approximately 0.06 million and 0.03 million shares of restricted stock vested, respectively. There were no forfeitures of restricted stock during the year ended December 31, 2021 and approximately forfeitures of 0.06 million shares of restricted stock during the years ended December 31, 2020. The fair market value of restricted shares for stock-based compensation expense is equal to the closing price of our common stock on the date of grant. The restrictions on the stock award are released generally over four years for senior management and over one year for board members. Stock-based compensation expense includes $0.2 million for the years ended December 31, 2021 and 2020, respectively for restricted stock. Of the restrictions on the stock awards granted during the periods ended March 31, 2017 and June 30, 2017, 20% was released in January 2018, and 10% annually beginning on the one-year anniversary of their offering thereafter for four years. The remaining 40% will be released evenly over four years beginning in 2018 contingent upon the attainment of annual performance goals established by our Board of Directors. Of the restrictions on the stock awards granted during the third quarter, the fourth quarter and the period ended December 31, 2017, respectively, one-fourth The following is a summary of stock option activity under the plans for the years ended December 31, 2021 and 2020: Weighted Average Number of Weighted - Remaining Aggregate Shares Average Contractual Intrinsic Value (in thousands) Exercise Price Term (Years) (in thousands) Options outstanding at January 1, 2020 438 $ 5.69 6.51 $ — Less options forfeited/cancelled (92) 5.29 Less options expired (3) 2.86 Options outstanding at December 31, 2020 343 $ 5.82 5.62 $ — Less options forfeited/cancelled (56) 4.31 Options outstanding at December 31, 2021 287 $ 6.11 4.37 $ — Options exercisable at December 31, 2021 287 $ 6.11 4.37 $ — The following is a summary of stock options outstanding under the plans as of December 31, 2021: Stock Options Outstanding Stock Options Exercisable Weighted Avg. Remaining Number of Contractual Weighted Avg. Number of Weighted Avg. Range of Exercise Prices Shares Life (years) Exercise Price Shares Exercise Price $ 4.11 $ 4.31 7,857 0.01 $ 4.11 7,857 $ 4.11 $ 4.32 $ 4.55 100,000 5.83 $ 4.50 100,000 $ 4.50 $ 4.56 $ 4.94 50,000 5.92 $ 4.60 50,000 $ 4.60 $ 4.95 $ 8.41 59,551 3.07 $ 6.09 59,551 $ 6.09 $ 8.42 $ 10.90 69,600 2.75 $ 9.75 69,600 $ 9.75 There are no unrecognized compensation costs as of December 31, 2021, as all stock options and restricted stock were fully vested as of December 31, 2021. There were no exercises for the years ended December 31, 2021, and 2020. The total fair value of stock awards vested was $0.4 million and $0.3 million during the years ended December 31, 2021 and 2020, respectively. There was no cash received from stock option exercises for the years ended December 31, 2021 and 2020. There were no net settlement exercises during the years ended December 31, 2021 and 2020. We have issued 0.2 million shares of stock related to restricted stock awards since the balance sheet date. Employee Stock Purchase Plan Under the Employee Stock Purchase Plan (“ESPP”), we are authorized to issue up to 0.55 million shares of our common stock to full-time employees, nearly all of whom are eligible to participate. Under the terms of the ESPP, employees may elect to have up to 15% of their gross compensation withheld through payroll deduction to purchase our common stock, capped at $25,000 annually and no more than 0.01 million shares per offering period. The purchase price of the stock is 85% of the lower of the market price at the beginning or end of each three-month participation period. As of December 31, 2021, there were less than 0.1 million shares available for purchase. For the years ended December 31, 2021 and 2020, there was no compensation expense recorded associated with grants under the ESPP which includes the fair value of the look-back feature of each grant as well as the 15% discount on the purchase price. This expense fluctuates each period primarily based on the level of employee participation. We did not receive any cash from our employee stock purchase plan for the years ended December 31, 2021 and 2020. We did not issue any shares related to the ESPP for the years ended December 31, 2021 and 2020. |